by Jasmine Batchelor
June 6, 2018
Vice President, Strategy and New Business Assessment,
Pfizer Innovative Health
Kirsten Axelsen is Vice President Strategy and New Business Assessment for Pfizer Innovative Health, leading a team responsible for setting the overall strategic course for the PIH business and the Patients First vision, and providing commercial assessments of business development and other partnership opportunities. Previously Kirsten led the Global Policy Team and Essential Health Strategy for Pfizer.
Kirsten earned a B.S. in Economics, from The University of Puget Sound, and an M.S. in Economics from the University of Texas, Austin. In 2006, Kirsten was awarded a Global Health Fellowship to work with the International Trachoma Initiative in Ethiopia.